Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer.

Abstract

Long noncoding RNAs (lncRNAs) are defined as RNAs longer than 200 nucleotides that do not encode proteins. Recent studies have demonstrated that numerous lncRNAs are expressed in humans and play key roles in the development of various types of cancers. Intriguingly, some lncRNAs have been demonstrated to be involved in endocrine therapy resistance for breast cancer through their own mechanisms, suggesting that lncRNAs could be promising new biomarkers and therapeutic targets of breast cancer. Here, we summarize the functions and mechanisms of lncRNAs related to the endocrine therapy resistance of breast cancer.

• Authors: Toshihiko Takeiwa, Kazuhiro Ikeda, Yuichi Mitobe, Kuniko Horie-Inoue, Satoshi Inoue
• Journal: Cancers (Cancers (Basel)) Vol. 12 Issue 6 (May 31 2020) ISSN: 2072-6694 [Print] Switzerland
• PMID: 32486413 (Publication Type: Journal Article, Review)